Crossmark Global Holdings’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-22,660
Closed -$444K 1273
2022
Q2
$444K Buy
22,660
+4,600
+25% +$96.4K 0.01% 857
2022
Q1
$391K Buy
18,060
+5,220
+41% +$111K 0.01% 1020
2021
Q4
$302K Buy
+12,840
New +$307K 0.01% 1148

Other funds holding SHC

Crossmark Global Holdings's SHC Position: Q3 2022 in Review

Crossmark Global Holdings sold out of Sotera Health (SHC) in Q3 2022, closing a stake of 22,660 shares — an estimated $444K sold.

Crossmark Global Holdings first reported a position in SHC in Q4 2021 and held it in 3 quarters. The position peaked at $444K in Q2 2022. 184 funds tracked by Wall St. Rank hold SHC as of Q3 2022.

  • Crossmark Global Holdings reported no remaining Sotera Health position as of Q3 2022 after selling out during the quarter.
  • Crossmark Global Holdings sold 22,660 Sotera Health shares in Q3 2022, an estimated $444K.
  • Crossmark Global Holdings first reported a position in Sotera Health in Q4 2021 and held it in 3 quarters.
  • Crossmark Global Holdings's Sotera Health position peaked at $444K in Q2 2022.
  • 184 funds tracked by Wall St. Rank held Sotera Health as of Q3 2022.

Based on Crossmark Global Holdings's 13F filing for Q3 2022, filed 1 Nov 2022.